Sign in
4

Changes in Ownership

CytoDyn Inc. Filed Acc 0000899243-21-040751

Options or other derivatives

  • President & CEO acquired 4,275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pourhassan Nader · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-18 Grant or award : show line 1 in the form Non-qualified Stock Option +4,275,000 4,275,000 D
Loading xslF345X03/doc4.xml…